Vaxart gets pummeled, losing a quarter of its value after earnings reporting and an update on the Covid vaccine processes. Novavax also whacked, falling just under 18%. Alnylam had a rough day, falling just under 9%.
BioNTech continues to rocket forward, gaining another 11% as its amazing run continues to gain momentum. GeoVax also had a strong day gaining over 6%.
Overall, there was a loss of 1.5% with 16 stocks losing ground while only ten gained ground.
No comments:
Post a Comment